Ainos (AIMD) Financials: History & Chart

Ainos, Inc.(AIMD)

Biotechnology · Houston, TX

$1.35+0.02 (+1.50%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

About Ainos, Inc.

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.

Houston, TX

41 employees

www.ainos.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Chun-Hsien Tsai

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	14K	152.00	161.00	11K	2K	5K	106K	0.00	0.00
Cost of Goods Sold	4.77M	1.19M	1.17M	1.20M	1.21M	1.20M	1.20M	-79.00	547.00
Gross Profit	-4.76M	-1.19M	-1.17M	-1.19M	-1.20M	-1.19M	-1.09M	79.00	-547.00
Gross Profit Margin	-34987.5%	-780350.0%	-729612.4%	-10724.3%	-55604.6%	-25529.6%	-1025.6%	N/A	N/A
Total Operating Expenses	9.01M	3.21M	1.11M	3.11M	1.58M	2.56M	2.07M	4.63M	3.04M
Research & Development	6.46M	1.85M	1.10M	2.12M	1.39M	1.91M	1.72M	2.33M	2.02M
Selling, General & Administrative	2.54M	1.36M	6K	982K	192K	643K	349K	2.31M	1.02M
Operating Income (EBIT)	-13.76M	-4.40M	-2.28M	-4.30M	-2.78M	-3.75M	-3.16M	-4.63M	-3.04M
Operating Margin	-101210.2%	-2894135.5%	-1418414.3%	-38648.0%	-128481.4%	-80327.8%	-2978.0%	N/A	N/A
Income Before Tax (EBT)	-14.45M	-4.59M	-2.46M	-4.47M	-2.93M	-4.08M	-3.29M	-4.65M	-3.70M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	731K	200K	177K	177K	177K	178K	180K	184K	265K
Other Income/Expense	-689K	-196K	-176K	-170K	-148K	-339K	-123K	-20K	-661K
Net Income	-14.45M	-4.59M	-2.46M	-4.47M	-2.93M	-4.08M	-3.29M	-4.65M	-3.70M
Income Tax Expense	800.00	0.00	0.00	800.00	0.00	0.00	0.00	800.00	0.00
Net Profit Margin	-106283.3%	-3022849.3%	-1527826.1%	-40182.5%	-135288.5%	-87604.3%	-3094.0%	N/A	N/A
EBITDA	-9.00M	-3.21M	-1.11M	-3.10M	-1.58M	-2.55M	-1.99M	-3.44M	-1.83M
EBITDA Margin	-66143.9%	-2113720.4%	-689175.8%	-27838.0%	-72798.9%	-54718.3%	-1869.6%	N/A	N/A
Depreciation & Amortization	4.77M	1.19M	1.17M	1.20M	1.21M	1.19M	1.18M	1.19M	1.21M
EPS Basic	-2.52	-0.62	-0.41	-0.85	-0.64	-0.99	-207.15	-0.49	-0.33
EPS Diluted	-2.52	-0.62	-0.41	-0.85	-0.64	-0.99	-207.15	-0.49	-0.33
Weighted Average Basic Shares	7.36M	7.36M	6.03M	6.03M	6.03M	6.03M	6.03M	9.50M	11.28M
Weighted Average Diluted Shares	7.36M	7.36M	6.03M	6.03M	6.03M	6.03M	6.03M	9.50M	11.28M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	124K	21K	122K	3.52M	595K	17K	12K	78K
Cost of Goods Sold	4.80M	53K	376K	2.11M	184K	11K	9K	65K
Gross Profit	-4.68M	-32K	-254K	1.41M	410K	5K	3K	13K
Gross Profit Margin	-3767.2%	-153.7%	-207.8%	39.9%	69.0%	31.9%	25.2%	16.5%
Total Operating Expenses	9.31M	13.81M	12.95M	15.38M	4.28M	1.45M	1.58M	1.35M
Research & Development	7.75M	8.41M	7.32M	6.85M	1.92M	389.00	53K	33K
Selling, General & Administrative	1.56M	5.40M	5.64M	8.54M	2.36M	1.45M	1.53M	1.31M
Operating Income (EBIT)	-13.99M	-13.84M	-13.21M	-13.98M	-3.87M	-1.44M	-1.58M	-1.33M
Operating Margin	-11268.3%	-66772.2%	-10815.0%	-397.1%	-650.5%	-8696.7%	-13472.1%	-1717.2%
Income Before Tax (EBT)	-14.77M	-14.86M	-13.77M	-14.01M	-3.87M	-1.45M	-1.58M	-1.34M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	712K	616K	144K	54K	19K	10K	885.00	4K
Other Income/Expense	-780K	-1.02M	-563K	-30K	-5K	-10K	-885.00	-4K
Net Income	-14.77M	-14.86M	-13.77M	-14.01M	-3.89M	-1.45M	-1.58M	-1.34M
Income Tax Expense	800.00	800.00	800.00	0.00	16K	0.00	0.00	0.00
Net Profit Margin	-11897.0%	-71702.3%	-11277.0%	-398.0%	-654.0%	-8758.2%	-13487.2%	-1722.3%
EBITDA	-9.21M	-9.04M	-8.34M	-9.16M	-1.82M	-1.43M	-1.56M	-1.28M
EBITDA Margin	-7418.2%	-43607.9%	-6826.0%	-260.3%	-306.6%	-8608.0%	-13282.5%	-1644.9%
Depreciation & Amortization	4.78M	4.80M	4.87M	4.81M	2.04M	15K	22K	56K
EPS Basic	-3.46	-1.56	-3.36	-5.14	-2.59	-2.69	-0.74	-0.56
EPS Diluted	-3.46	-1.56	-3.36	-5.14	-2.59	-2.69	-0.74	-0.56
Weighted Average Basic Shares	4.27M	9.50M	4.10M	2.73M	1.51M	543K	2.15M	2.38M
Weighted Average Diluted Shares	4.27M	9.50M	4.10M	2.73M	1.51M	543K	2.15M	2.38M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.